Experts Present New Radiosurgery Techniques Using Varian Technology for Optimal Targeting of Multiple Metastases

Thursday, May 25, 2017 General News
Email Print This Page Comment bookmark
Font : A-A+

Researchers to highlight advances in radiosurgery at International Stereotactic Radiosurgery Society (ISRS)

PALO ALTO, Calif., May 25, 2017 /PRNewswire/ -- Clinical experts in stereotactic radiosurgery will discuss

new techniques using Varian Medical Systems' (NYSE:VAR) Edge radiosurgery system for the noninvasive, simultaneous treatment of multiple metastases in the brain, spine, head & neck, and lung at the International Stereotactic Radiosurgery Society (ISRS) meeting in Montreux, Switzerland, from May 28-June 1, 2017.

As a Gold Sponsor of the 13th biennial ISRS, Varian is featuring an industry-sponsored session on May 28th that includes a hands-on presentation by the Varian Eclipse Product Management Team preceded by a detailed presentation from Glasgow's Beatson West / Scotland Cancer Center on the "Validation of HyperArc High Definition Radiotherapy for Multiple Metastases."  The Varian team will demonstrate how the Eclipse™ software serves as a comprehensive treatment planning system that enables clinicians to create, import, and optimize plans across numerous multiple linear accelerators.

On May 29th, Varian will sponsor a symposium entitled, "Edge Radiosurgery: Accuracy, Efficiency, and Flexibility," featuring speakers from five major radiosurgery centers. The program features two neurosurgeons and two neuro-radiation oncologists from the US and a medical physicist from the UK. Researchers from the Clatterbridge Cancer Center in Clatterbridge, UK, will address the radiological accuracy and precision of Edge, which delivers highly conformal dose distributions to multiple metastases in a single fraction and with one isocenter for quick, efficient, non-invasive treatments.

Oncology professionals will also present innovative approaches to radiosurgery using Varian's Edge® radiosurgery system, including RapidArc® and HyperArc. Experts from the University of California San Diego and Memorial Sloan Kettering/Cornell University in New York will discuss their work using RapidArc radiotherapy to efficiently and simultaneously deliver doses that closely match the size, shape and location of multiple lesions by using a single focal point and a small number of rotations.

Researchers from the University of Alabama, Birmingham, will discuss their work with Varian's high definition radiosurgery technology, HyperArc which uses more beam angles to dramatically compresses dose distribution.  The researchers will also share their work using optimized beam shaping for ultra-precise dose delivery from an accelerator equipped with a high-definition multileaf collimator as well as specialized treatment planning for radiosurgery in the brain.

Work on Varian's Velocity™ clinical intelligence platform for managing extended metastatic disease will be presented by clinical professionals from Emory University, Atlanta. Velocity brings virtually all imaging scans and treatment information together into a consolidated view for faster, more informed, collaborative decisions.

For more information, visit the ISRS 2017 website at http://www.isrsy.org/public/en/news//isrs-congress-2017-in-montreux/art_id/1

About Varian Medical SystemsVarian Medical Systems focuses energy on saving lives and is the world's leading manufacturer of medical devices and software for treating and managing cancer. Headquartered in Palo Alto, California, Varian employs approximately 6,400 people around the world. For more information, visit http://www.varian.com and follow @VarianMedSys on Twitter.

Press Contact

Mark PlungyVarian Medical Systems+1 (650) 424-5630 [email protected]

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/experts-present-new-radiosurgery-techniques-using-varian-technology-for-optimal-targeting-of-multiple-metastases-300463543.html

SOURCE Varian Medical Systems



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Find a Doctor
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook